May 14, 2014 / 5:28 AM / 3 years ago

BRIEF-Ablynx posts Q1 net loss 2.8 mln euros

May 14 (Reuters) - Ablynx Nv :

* Q1 revenues of 11.2 mln euros

* Q1 net loss of 2.8 mln euros (2013: 6.7 mln euros)

* Anticipated that top-line phase II data from Titan study with Caplacizumab will be reported in June 2014

* Expects to keep net cash burn in 30 mln euros - 35 mln euros range for 2014 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below